BRISTOL-MYERS SQUIBB's VIDEX (ddI) RECOMMENDED FOR APPROVAL IN TREATING AIDS IN ADULTS AND CHILDREN INTOLERANT OR RESISTANT TO RETROVIR (AZT)

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".